We do have that information. Obviously, we have plans for every single country. The good news is that right now, there's been a pretty broad distribution of vaccines, both mRNA vaccines and vector-based vaccines. In the past, we've used some inactivated vaccines, but those have been less in demand. We now have adjuvanted proteins, which have not yet taken off, but we expect over time, as people understand their characteristics, they will be taken up. We can submit that.
On April 25th, 2022. See this statement in context.